Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

OcuSciences Secures EU CE Clearance and Expands European Presence with OcuMet Beacon Instruments

OcuSciences, a medical device company developing advanced ocular imaging technologies to help clinicians better understand retinal dystrophies and other leading causes of blindness, today announced that it has received EU CE clearance for its OcuMet Beacon, a breakthrough diagnostic instrument designed to enhance the assessment of eye health.

In conjunction with this regulatory milestone, OcuSciences has deployed OcuMet Beacons in leading medical centers across Europe and the United Kingdom, marking a significant step forward in its mission to transform eye care globally.

EU CE clearance confirms that the OcuMet Beacon meets the stringent health, safety, and environmental protection standards required for commercialization across the European Economic Area. This achievement underscores OcuSciences’ commitment to delivering innovative, reliable, and accessible imaging solutions that empower eye care professionals worldwide.

“Securing CE clearance is a major milestone for OcuSciences and reflects our dedication to advancing the standard of care in ophthalmology,” said Kurt Riegger, CEO of OcuSciences. “The growing adoption of our technology by leading ophthalmic clinical centers across Europe highlights its unique value and diagnostic potential to improve disease detection and management and particularly helpful in monitoring treatment.”

The initial installations span prominent research institutions, hospitals, and specialized ophthalmic centers in Germany, England, and Wales. Each site will integrate the OcuMet Beacon into its clinical studies and research programs, further validating the technology’s real-world impact and driving advancements in ocular imaging.

According to the World Health Organization, more than 2.2 billion people worldwide experience vision impairment, making earlier and more detailed assessment essential for effective treatment. By deploying the OcuMet Beacon, OcuSciences aims to equip clinicians with the tools needed to detect disease earlier and improve outcomes for patients around the world.

About OcuSciences, Inc.

OcuSciences, Inc., is a commercial-stage biotechnology company developing retinal imagers to identify the signatures of disease occurring in the retina for improved detection of disease. Its flagship product, the OcuMet Beacon, has been developed to automatically, rapidly, and non-invasively assess retinal markers of disease, in a patient’s eye. OcuSciences has shown preliminary clinical utility in a number of disease states, including diabetic retinopathy, glaucoma, and age-related macular degeneration. Learn more at www.ocusciences.com.

“The growing adoption of our technology by leading ophthalmic clinical centers across Europe highlights its unique value and diagnostic potential to improve disease detection and management and particularly helpful in monitoring treatment."

Contacts

For media inquiries or more information, please contact:

Kurt Riegger

(734) 623-9434

info@ocusciences.com

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.